The Global Soft tissue sarcoma (STS) Market has been estimated to grow with a CAGR of 7.4% during the forecast year and was holding a revenue of US$ 3,595.41 Mn in 2022 and is projected to reach US$ 6,465.70 Mn by 2030.
Global Medical rehabilitation services market was valued at US$ 315.6 million in 2023 and is expected to reach a valuation of US$ 600.0 million by 2032 at a CAGR of 7.4% during the forecast period of 2024–2032.
Asia Pacific stem cell therapy market was valued at US$ 1,688.04 million in 2024 and is poised to reach valuation of US$ 4,075.75 million by 2033, growing at a CAGR of 10.29% during the forecast period 2025–2033.
Exosome research market was valued at US$ 236.99 million in 2024 and is anticipated to record a revenue of US$ 1,690.88 million by 2033 at a CAGR of 24.4% over the Forecast Period of 2025 to 2033.
India specialty drug distribution market generated a revenue of US$ 2,045.35 million in 2022 and is estimated to reach a valuation of US$ 5,997.7 million by 2031 at a CAGR of 12.93% during the forecast period 2023–2031.
ASEAN nutritional supplements market generated revenue of US$ 7,366.8 million in 2022 and it is estimated to reach valuation of US$ 14,847.3 million by 2031 at a CAGR of 8.4% during the forecast period, 2023–2031.
ASEAN & US corporate wellness market is anticipated to reach valuation of US$ 30.82 Bn in 2030 from US$ 18.29 Bn in 2021. The market is expected to register healthy growth at a CAGR of 5.88 % during the forecast period 2022–2030.
Japan pet cancer therapeutics market was valued at US$ 15.3 Million in 2024 and is projected to reach a valuation of US$ 29.1 Million by 2033 at a CAGR of 7.34% during the forecast period 2025-2033.
Global dermatology drugs market was valued at US$ 19.71 billion in 2023 and is estimated to reach a valuation of US$ 50.42 billion by 2032 at a CAGR of 11.0% during the forecast period 2024-2032.